Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chagasic myocardiopathy: historical perspective].

M V Elizari1

  • 1Centro de Asistencia Integral del Paciente Chagásico, Hospital General de Agudos José Maria Ramos Mejía, Buenos Aires, Argentina.

Medicina
|February 11, 2000
PubMed
Summary

Chagas disease, caused by Trypanosoma cruzi, affects millions globally. Autoimmune mechanisms are key to its cardiac damage, leading to dilated cardiomyopathy and arrhythmias in chronic stages.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The normal variants in the left bundle branch system.

Journal of electrocardiology·2017
Same author

Efficacy of amiodarone for the termination of chronic atrial fibrillation and maintenance of normal sinus rhythm: a prospective, multicenter, randomized, controlled, double blind trial.

Journal of cardiovascular pharmacology and therapeutics·2002
Same author

Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction.

Circulation·2001
Same author

Lidocaine-sensitive atrial tachycardia: lidocaine-sensitive, rate-related, repetitive atrial tachycardia: a new arrhythmogenic syndrome.

Journal of the American College of Cardiology·2000
Same author

Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease.

Journal of pineal research·2000
Same author

Morbidity and mortality following early administration of amiodarone in acute myocardial infarction. GEMICA study investigators, GEMA Group, Buenos Aires, Argentina. Grupo de Estudios Multicéntricos en Argentina.

European heart journal·2000

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Immunology

Context:

  • Chagas disease, caused by Trypanosoma cruzi, impacts 18 million people, with 100 million at risk in Latin America.
  • The disease progresses through acute, undifferentiated, and chronic stages, with cardiac involvement being a major concern.
  • Understanding Chagas disease pathogenesis is crucial for developing effective treatments.

Purpose:

  • To review the clinical, pathological, and pathogenic aspects of Chagas disease.
  • To highlight the natural history and diagnostic methods for Chagas disease.
  • To explore the role of autoimmune mechanisms in Chagasic myocarditis.

Summary:

  • Chagas disease presents in acute, undifferentiated, and chronic phases, often leading to dilated cardiomyopathy and arrhythmias.
  • Diagnosis relies on epidemiology, serology, and clinical findings like ECG abnormalities and apical aneurysms.
  • Pathogenesis involves autoimmune responses, with antibodies cross-reacting between Trypanosoma cruzi and human antigens.

Impact:

  • Advances in understanding Chagas disease pathogenesis, particularly autoimmune mechanisms, can guide therapeutic strategies.
  • Improved diagnostic approaches, including sensitive tests for latent forms, aid early intervention.
  • This review provides a comprehensive overview for clinicians and researchers, facilitating better patient management and disease control.

Related Experiment Videos